Scimega Competitors and Similar CompaniesClear all
Xintela's competitors and similar companies include Innate Pharma.
 Innate Pharma Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients. | ||
Founding Date | Founding Date 2009 | Founding Date 1999 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Lund, SE HQ Lund, SE Lund, SE | Locations Marseille, FR HQ Rockville, US |
Employees | Employees 15 | Employees 181 |
Financial | ||
Revenue (est.) | Revenue (est.) kr2.3m (FY, 2025) | Revenue (est.) €2.8m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods €266k (FY, 2025) |
Gross profit | Gross profit kr2.3m (FY, 2025) | Gross profit €8.7m (FY, 2025) |
Net income | Net income (kr48.6m) (FY, 2025) | Net income (€49.2m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 934.5k | Total funding raised $ 94.1m |
For sources of this data, please see the company profile
View Company Profiles
Innate Pharma
HQ
Marseille, FR
Employees
181
Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients.
View company